Wegovy & MASH

Video will be live on Monday, October 20 at 1:00 PM Central Time. 

▪️ Join my channel to get access to perks or simply subscribe and turn on your notifications!
▪️ Download my FREE GLP-1/GIP Medication Information Sheet and 7-Day Best Weight Journal here.
▪️ Join my Empowerment Hub and discover sustainable, evidence-based solutions to transform your health and embrace self-care without guilt.

👉 Enjoy lifetime free access to Daily Momentum and Nourish & Thrive, your go-to spaces for daily support, encouragement, and practical tips. Or, become a Core Member for just $15/month or $145/year to unlock expert coaching, exclusive resources, and a proven system that includes live Q&As and monthly toolkits, to help you create real, lasting change.
🔗 https://drdanshub.com

Wegovy’s New Role in MASH:
7 Early Signs + 7 Ways to Protect Your Liver

There’s a disease quietly damaging the livers of millions—often without pain or warning. It’s called MASH, and Wegovy, the well-known weight loss medication, has just been FDA-approved to treat it.

In this video, I explain what MASH is, why it develops, and the early signs most people miss—like fatigue, brain fog, and bloating. I also share what Wegovy’s new approval means for treatment and prevention, plus simple ways to protect your liver before serious damage occurs.

MASH is often silent, but it’s not unstoppable. With the right awareness and action, you can catch it early and protect your health. No fluff, no shame—just real talk about keeping your liver strong.

Thanks for watching and always remember: small tweaks lead to massive peaks!

Don’t forget to hit the subscribe button for more insightful content, and consider joining our YouTube Members Membership for exclusive content and early access to weekly videos. 

📺 Watch These Next:
▪️ Watch This Before Taking Mounjaro
▪️ From Ozempic to Mounjaro
▪️ Muscle Loss with Ozempic, Wegovy & Mounjaro
▪️ Managing Nausea from Ozempic, Wegovy and Trulicity!
▪️ Ozempic: Stomach Paralysis Update
▪️ How to Switch from Ozempic (or Wegovy) to Mounjaro
▪️ Ozempic Paralyzed My Stomach
▪️ How to Inject Mounjaro: step-by-step tutorial

🎯 Free Resources:
▪️ GLP-1/GIP Medication Info Sheet + 7-Day Food Journal
▪️ Total Daily Energy Expenditure (TDEE) Calculator – Find your optimal calorie intake


🛒 Recommended Products for Your Weight-Loss Journey:
▪️ Managing Constipation
▪️ Managing Heartburn
▪️ Protein Bars & Supplements
▪️ Activity Trackers & Scales

Live in Alberta? Come see me at my Pharmacist-led Obesity Clinic at Apothecare Pharmacy – http://apothecarerx.ca 

 

Dr. Dan

Follow me on social media for regular updates – @TheOfficialDrDan

Subscribe to my newsletter for a heads-up on all new content.

Sharing is caring! Here’s the social, email, and even text link –
https://healthevolved.co/wegovy-mash

If you need some coaching support on your weight management journey, you can book a consultation with me to see if you’d be a good fit for our program. 

Questions or comments? Please send them my way on our Contact Us page!

Share:

More Posts

The Ozempic Pill Has a Ceiling — New Trial Proves It

New clinical trial data on orforglipron reveals a biological ceiling that every person on GLP-1 medications needs to understand. I’m breaking down the ATTAIN-MAINTAIN trial findings, explaining what the 15% threshold means for long-term weight management, and identifying exactly who is — and isn’t — a strong candidate for the transition to the Ozempic pill.

Reducing Your Zebound Dose Could Undo ALL Your Progress

The SURMOUNT MAINTAIN trial has delivered the most compelling evidence yet that obesity requires long-term management — not a finish line. New data reveals exactly what happens to your results at every dose decision, and the numbers make the choice undeniable.

The Retatrutide Paradox: Why This “Triple Threat” Works

Retatrutide is a triple-action therapy targeting GLP-1, GIP, and glucagon receptors simultaneously — a fundamentally different design from current treatments. Early clinical data reveals significant liver-fat reductions and an unexpected paradox: a receptor long assumed to raise blood sugar instead helps mobilize stored fat and support resting metabolism.

Retatrutide TRIUMPH-1 Results: 28% Weight Loss

TRIUMPH-1 Phase 3 trial data reveals retatrutide achieved up to 30% body weight loss — outperforming bariatric surgery benchmarks without a single incision. I’m breaking down the full efficacy numbers, safety signals, and what this triple-hormone agonist means for your weight management options right now.

Send Us A Message

Try My New Calorie Calculator!

Calculate your daily calorie and protein targets to help you achieve your weight goals.

Try My New Calorie Calculator!

Calculate your daily calorie and protein targets to help you achieve your weight goals.